CUSIP 126638105COMCVRXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
91 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 4.02M | $28.58M | −78.6K | Reduced |
| 2 | Nea Management Company, LLC | 2.03M | $14.39M | 0 | Held |
| 3 | Vanguard Group Inc | 1.12M | $7.96M | +30.4K | Added |
| 4 | Blackrock, Inc. | 1.06M | $7.53M |
| +45.4K |
| Added |
| 5 | Gsk PLC | 1.01M | $7.15M | +1.01M | New Position |
| 6 | Balyasny Asset Management L.P. | 814.9K | $5.79M | +118.7K | Added |
| 7 | Silvercrest Asset Management Group LLC | 634.6K | $4.51M | +275.3K | Added |
| 8 | Parkman Healthcare Partners LLC | 413.0K | $2.93M | −78.4K | Reduced |
| 9 | Geode Capital Management, LLC | 403.9K | $2.87M | −1.0K | Reduced |
| 10 | Morgan Stanley | 380.6K | $2.70M | −50.9K | Reduced |
See every fund holding Cvrx Inc, with full quarter-over-quarter share changes.
Unlock all holders